Almac to Host Inaugural European Product Launch Workshop for US Biopharmaceutical Companies

CRAIGAVON, Northern Ireland, May 11, 2011 - Almac is hosting its inaugural European Product Launch
workshop in Boston, MA on 17th May 2011. Targeted specifically at the
biopharmaceutical sector, the workshop provides consultative advice and
services to US companies to successfully launch drug products onto the
European market.

The workshop will provide US companies with important market
and regulatory framework knowledge, whilst guiding them through the European
product launch process right through from submitting an MAA to final
distribution of drug products to end-users.

Attendees will also learn from the real life experiences of
three of Almac's many US clients who have successfully launched drug products
into the European marketplace including: Eisai Inc, Millennium: The Takeda
Oncology Company and The Medicines Company.

Ian Markwell, VP of Quality for Almac's Pharma Services
business unit commented 'This workshop provides a significant opportunity for
US companies to learn first hand of the processes of launching product into
Europe, as many companies based outside the EU, find the European regulatory
and quality framework complex.'

One of the key presenters at the workshop Ms Trudy Burke,
Senior Director, Baltimore & Gliadel Operations, Eisai Inc remarked: 'I am
delighted to share my experience of partnering with Almac, while helping to
advise US companies on the challenges of launching a high value, temperature
sensitive product in Europe.'

Further details of this workshop can be found at
almaceuproductlaunch.eventbrite.com or by contacting Tania Davis
(Tania.davis@almacgroup.com) directly.

About Almac Group

The Almac Group provides a broad range of services from R&D,
biomarker discovery and development, API manufacture, pharmaceutical
development, clinical trial supply and IXRS(R) technology (IVRS/IWRS), to
commercial-scale manufacture and packaging. Almac provides services to more
than 600 companies, including all the world leaders in the pharmaceutical and
biotech sectors.

The company employs over 3,000 individuals and is
headquartered in Craigavon, Northern Ireland. US operations are based in
Pennsylvania, North Carolina and California. Almac has now moved into its new
North American Headquarters located in Souderton PA.

For more information about the Almac Group, please visit
www.almacgroup.com or e-mail info@almacgroup.com

    Contact:

    Tania Davis
    Almac Pharma Services
    T: +44(0)28-3836-3363
    E : tania.davis@almacgroup.com

    OR

    Tristan Jervis
    DeFacto
    T.Jervis@Defacto.com
    Tel: +44-2078-613019

.